Strides Pharma Science (NSE:STAR) Days Sales Outstanding : 96.12 (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Strides Pharma Science Days Sales Outstanding?

Strides Pharma Science's average Accounts Receivable for the three months ended in Mar. 2024 was ₹11,419 Mil. Strides Pharma Science's Revenue for the three months ended in Mar. 2024 was ₹10,840 Mil. Hence, Strides Pharma Science's Days Sales Outstanding for the three months ended in Mar. 2024 was 96.12.

The historical rank and industry rank for Strides Pharma Science's Days Sales Outstanding or its related term are showing as below:

NSE:STAR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 92.87 Med: 127.92 Max: 161.82
Current: 110.32

During the past 13 years, Strides Pharma Science's highest Days Sales Outstanding was 161.82. The lowest was 92.87. And the median was 127.92.

NSE:STAR's Days Sales Outstanding is ranked worse than
79.1% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs NSE:STAR: 110.32

Strides Pharma Science's Days Sales Outstanding declined from Mar. 2023 (120.21) to Mar. 2024 (96.12).

Strides Pharma Science Days Sales Outstanding Historical Data

The historical data trend for Strides Pharma Science's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strides Pharma Science Days Sales Outstanding Chart

Strides Pharma Science Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

131.81

114.64

139.98

124.03

109.98

Strides Pharma Science Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															120.21	127.50	112.47	108.33	96.12

Competitive Comparison of Strides Pharma Science's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Strides Pharma Science's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Strides Pharma Science's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Strides Pharma Science's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Strides Pharma Science's Days Sales Outstanding falls into.

Strides Pharma Science Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Strides Pharma Science's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (12994.02	+	11418.74)	/	2 )	/	40511.24	*	365
=	12206.38					/	40511.24	*	365
=	109.98

Strides Pharma Science's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	11418.74)	/	1 )	/	10840.35	*	365 / 4
=	11418.74					/	10840.35	*	365 / 4
=	96.12

Strides Pharma Science (NSE:STAR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Strides Pharma Science Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Strides Pharma Science (NSE:STAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (NSE:STAR) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

532531:India

Address

Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076

Website

https://www.strides.com

Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market strategy focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Strides Pharma Science (NSE:STAR) Headlines

No Headlines